Terray Therapeutics
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $120.0Mattributed |
|---|---|
| Latest round | series-b, $120.0M, 2024-10-01attributed |
| Founded | unknown |
| Headquarters | Los Angeles CA |
| Industry | biotech|drug-discovery|ai |
| Stage | series-b+ |
| Website | terraytx.com |
Terray Therapeutics is a drug discovery company that combines AI with high-throughput experimentation to design small-molecule medicines. It develops therapeutics across multiple disease areas through its EMMI platform. Terray is vertically integrated, inventing its own hardware and chemical datasets rather than buying third-party tools.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-10-01 | series-b | $120.0M | undisclosed |
Detected tech stack
Vercel, Next.js, Sanity, Sanity.io, web-vitals, React, Webpack
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $120.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $120.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | terraytx.com, read 2026-05-07 |
| Description | self-reported | terraytx.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.